Background: Recent studies suggested a role of diabetes in regulating the outcome of pulmonary hypertension. Several cytokines are dysregulated in pulmonary hypertension, and were considered accurate predictors of the prognosis. Aim of Study: To evaluate the effects of glycemic control on hemodynamics, metabolic and adipokines (leptin, apelin and adiponectin) levels in patients with pulmonary hypertension and diabetes. Subjects and Methods: Thirty-five pulmonary hypertension patients with diabetes assigned into two groups according to glycosylated hemoglobin (HbA1c) level; tightly controlled group (Group I) (n=20) and conventionally controlled group (Group II) (n=15). Demographic characteristics, hemodynamic assessment, metabolic and serum adipokines levels were assesed. Results: Both groups showed insignificant difference in age, BMI and left ventricular ejection fraction; while mean pulmonary arterial pressure, HbA1c, fasting blood glucose, insulin, HOMA-IR, Cholesterol, triglycerides, Interleukin-6, leptin and apelin were significantly decreased in group I. IL-6, leptin and apelin have significant positive correlation with glucose, insulin, HOMA-IR, Cholesterol, TG and MPAP in both groups. Conclusion: Good glycemic control has an impact on hemodynamics, metabolic, inflammatory and adipokine pattern in diabetic patients with pulmonary hypertension, which may affect the progression of the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.